GlucoTrack Inc. (GCTK): יחס שווי פעילות לרווח לפני ריבית, מסים ופחת
GlucoTrack, Inc. (GCTK) develops glucose monitoring systems. Risks are linked to fierce competition and the complexity of device certification, while the EV/EBITDA value for the shares shown on this price chart is 0.00. Production relies on a fabless model utilizing US contract manufacturers. The R&D department is focused on creating intravascular implantable sensors, which are currently in the engineering preparation stage for testing.
פילוחי מדדים מקיפים ואנליטיקה עבור GlucoTrack Inc. (GCTK)
The operational efficiency of GlucoTrack, Inc. (GCTK) is reflected via the EV/EBITDA ratio on the valuation chart. This multiple compares the total enterprise value of the business with its earnings before interest, taxes, depreciation, and amortization, allowing for an assessment of the real value of production capacities. For a company investing in highly skilled bioengineers and RSU programs, this indicator determines whether the market capitalization is fair relative to the generated cash flow.
